SCHEMBL7792899

SCHEMBL7792899

NC(=O)CC(O)C(O)CC(=O)NOCc1ccccc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
PARP15 Q460N3 2/20 0.44
PARP10 Q53GL7 2/20 0.44
MAOB P27338 2/20 0.44
PARP14 Q460N5 1/20 0.44
SCN3A Q9NY46 2/20 0.43
IDO1 P14902 2/20 0.41
SCN9A Q15858 1/20 0.41
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
SLC1A5 Q15758 1/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
AURKA O14965 1/20 0.38
MAP2K1 Q02750 1/20 0.38
PTK2 Q05397 1/20 0.38
ITGB2 P05107 1/20 0.37
ICAM1 P05362 1/20 0.37
ITGAL P20701 1/20 0.37
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793844 0.84 IDO1 (0.44) ALDH1A1MAOBIDO1MAPK8MEN1
SCHEMBL7792917 0.80 NPC1 (0.51) NPC1RAB9A
SCHEMBL7789774 0.78 MAOB (0.41) ALDH1A1PARP10MAOBIDO1LMNA
SCHEMBL7792926 0.76 MAOB (0.46) PARP10MAOBIDO1SCN9A
SCHEMBL28808707 0.75 ALDH1A1 (0.76) ALDH1A1PARP15PARP10MAOBPARP14
SCHEMBL7792895 0.75 ALDH1A1 (0.47) ALDH1A1PARP15PARP10MAOBPARP14
SCHEMBL7347119 0.72 RAB9A (0.54) ALDH1A1PARP10MAOBLMNAMAPK8
SCHEMBL15761245 0.70 ALDH1A1 (0.67) ALDH1A1PARP15PARP10MAOBPARP14
SCHEMBL30211075 0.68 ALDH1A1 (0.64) ALDH1A1PARP15PARP10MAOBPARP14
SCHEMBL5766366 0.68 ALDH1A1 (0.64) ALDH1A1PARP15PARP10MAOBPARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044547-A1 Antiviral protease inhibitors MEDIVIR AB 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044547-A1 Antiviral protease inhibitors PEPD, PREP, CTSL ALDH1A1 1578/4885PARP15 1365/4885PARP10 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.